Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1167 | Male Reproduction | ECE2017

Early arterial stiffness and chronic inflammation in male equivalents of polycystic ovary syndrome

Sozen Mehmet , Baldane Suleyman , Abusoglu Sedat , Kebapcilar Levent , Kebapcilar Aysegul , Akyurek Fatma , Unlu Ali , Ipekci Suleyman Hilmi

Introduction: There is some evidence that a rise in the androgen hormone levels increases the risk for the development of a cardiovascular disease, obtained from the studies conducted on women with polycystic ovary and on men with androgenic alopecia. Inflammatory substances tend to increase in polycystic ovary syndrome and in androgenic alopecia. On this basis, we conducted a study that aimed to evaluate the early cardiovascular and metabolic effects in male patients with and...

ea0056p625 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2018

Is SFRP-4 an early potential biomarker related to diabetes and hypertension, in patients with androgenic alopecia?

Ipekci Suleyman , Sozen Mehmet , Abusoglu Sedat , Baldane Suleyman , Akyurek Fatma , Kirac Cem Onur , Kebapcilar Ayse Gul , Unlu Ali , Kebapcilar Levent

Androgenic alopecia (AGA) is an important clinical issue that can cause significant cosmetic problems. Many factors such as genetic, androgen hormones, environmental factors, and inflammation are involved in the pathogenesis of androgenic alopecia. Insulin and insulin resistance have been found increased in individuals with AGA. There are many proinflammatory substances which are playing role in the pathogenesis of androgenic alopecia. Secreted frizzled related protein-4 (SFRP...